|
LXEO Lexeo Therapeutics Inc 1907108 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-20,196,000.00 |
| Balance Sheet |
|
Current Assets
|
$200,862,000.00 |
|
Assets
|
$250,356,000.00 |
|
Current Liabilities
|
$14,189,000.00 |
|
Liabilities
|
$18,859,000.00 |
|
Equity
|
$231,497,000.00 |
|
Shares Out
|
74086737.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-21,144,000.00 |
|
Investing Cash Flow
|
$27,460,000.00 |
| Market Analysis |
Market Cap
|
$322,277,305.95 |
|
Price
|
$4.01 |
|
BVPS
|
3.12 |
|
PB
|
1.39 |
|
EPS
|
-0.25 |
|
FCF
|
$-21,179,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:27 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-0.27 |
|
|
2026-05-11 |
-0.25 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.60 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.33 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LXEO documents filed with the SEC.
LXEO Filings
Clear
